Researchers studied the plant Pueraria lobata for its potential health benefits, particularly in lowering blood sugar, improving insulin sensitivity, and inhibiting obesity. The specific mechanism of how it inhibits obesity is still unclear, making further study necessary.
Researchers isolated flavonoids from kudzu plant and found they lower blood sugar levels and may treat diabetes by targeting SGLT2, PTP1B, and AG enzymes. This study provides insight into the plant's potential health benefits.
Puerarin (Pue) from Pueraria lobata protects against vascular damage induced by diabetes by reducing inflammation and oxidative stress through inactivating the ROS-NLRP3 signaling pathway. This could potentially lead to new treatments for diabetic vascular diseases.
Puerarin from Pueraria lobata improved metabolic syndrome in rats, reducing cardiovascular damage, inflammation, and improving glucose and lipid metabolism. Dietary supplementation with PUE could be beneficial in managing and preventing MetS and CVDs.
Herbal remedies in traditional Chinese medicine show promise in managing SCA3 by targeting oxidative stress. Preclinical studies support their therapeutic roles, suggesting potential alternative treatments to delay disease progression.
Researchers studied the therapeutic effects of Pueraria lobata water extract for treating myocardial infarction in rats. They found that the extract reduced cardiac injury, improved amino acid levels, and restored intestinal flora balance. This study provides new insights into the potential of Pueraria lobata in heart disease treatment.